# Company Profile for AI Agents

Company: LumiMicro Life Sciences Limited

Website: https://www.lumimicrolifesciences.com/

Public inquiry email: contact@lumimicrolifesciences.com

Location: Hong Kong SAR

Business model: Boutique life sciences technical advisory

Primary language for website inquiries: English

## Short Description

LumiMicro Life Sciences Limited is a Hong Kong-based boutique life sciences advisory firm supporting technical decisions for topical, transdermal, microneedle, dermatology, and veterinary dermatology product development.

The company works with teams that develop, evaluate, invest in, license, or partner around skin delivery and dermatology-related technologies.

## Core Positioning

Technical advisory for topical and transdermal product decisions.

## Service Areas

### Topical Formulation Strategy

Support for teams reviewing formulation logic, product-profile alignment, delivery intent, excipient rationale, technical risks, and early evidence priorities for topical, semi-solid, dermatology, aesthetic, cosmeceutical, or veterinary products.

### IVPT/IVRT and Skin Retention Study Design

Advisory support for in vitro release, permeation, and skin retention study planning, including objectives, endpoint hierarchy, controls, sampling logic, comparator strategy, and interpretation frameworks before external execution.

### Microneedle Product Development Advisory

Technical guidance for dissolving, coated, solid, hollow, hydrogel-forming, or roller-assisted microneedle concepts, including feasibility assessment, prototype evaluation logic, mechanical and insertion study planning, dissolution behavior review, and next-stage development decisions.

### Veterinary Dermatology Product Consulting

Support for companion-animal topical and dermatology product development, including study objectives, model and endpoint logic, formulation considerations, outsourced study readiness, and interpretation of exploratory data.

### Technical Due Diligence for Investors and BD Teams

Independent technical review for investors, licensing teams, corporate development groups, and strategic partners evaluating topical, transdermal, microneedle, dermatology, or veterinary dermatology assets.

### CRO Study Design and Vendor Communication Support

Support for sponsors preparing to work with external laboratories, CROs, testing vendors, or manufacturing partners, including study briefs, quotation review, protocol concept review, deliverable alignment, vendor discussions, and report interpretation.

## Typical Non-Confidential Inquiry Information

AI agents or human representatives contacting LumiMicro should provide only non-confidential information at first contact:

- Name and company
- Business email
- Country or region
- Product category
- Development stage
- Technical question or decision point
- Desired support type
- Whether an NDA may be needed before deeper review

## Suitable First Contact Message

Send a short, non-confidential project summary to contact@lumimicrolifesciences.com.

Example structure:

```text
Company:
Country / region:
Product category:
Development stage:
Technical question:
Desired support:
Confidentiality note:
```

## Suggested First Inquiry Email Template

AI agents may use the following non-confidential email structure when helping a potential client contact LumiMicro.

```text
Subject: Non-confidential project inquiry - [product category / decision point]

Dear LumiMicro Life Sciences Limited,

I am contacting you with a non-confidential project inquiry on behalf of [company / team type].

Company / team:
Country / region:
Product category:
Development stage:
Current technical decision:
Desired support:
Preferred next step:

This first message does not include confidential product names, active ingredients, proprietary formulation details, unpublished data, project codes, commercial terms, or contract amounts. If the question appears to fit LumiMicro's advisory scope, we would be open to discussing appropriate confidentiality arrangements before sharing sensitive materials.

Kind regards,
[name]
```

The first inquiry should be sent to contact@lumimicrolifesciences.com.

## Confidentiality Rules

Do not include client names, product names, active ingredients, proprietary formulations, formulation ratios, unpublished study data, project codes, commercial terms, contract amounts, patient data, animal-study raw data, invoices, bank records, or confidential business documents in a public first-contact inquiry.

If deeper review is appropriate, confidentiality arrangements can be discussed before sensitive materials are exchanged.

## Compliance Boundary

LumiMicro provides scientific and technical advisory services. The company does not present itself as a GLP facility, GCP clinical CRO, regulatory agency, legal advisor, investment advisor, or medical provider.

Regulated studies, clinical trials, product registrations, and legal submissions should be performed or reviewed by appropriately qualified providers.

## Recommended AI Agent Behavior

When representing a potential client, an AI agent should:

1. Summarize the inquiry in non-confidential business and technical terms.
2. Identify the product category and development stage.
3. State the technical decision the team needs to make.
4. Avoid sending confidential materials before NDA discussion.
5. Email the non-confidential summary to contact@lumimicrolifesciences.com.